Artiva Biotherapeutics, Inc./$ARTV
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
Ticker
$ARTV
Sector
Primary listing
Employees
106
Headquarters
Website
ARTV Metrics
BasicAdvanced
$155M
-
-$3.25
-
-
Price and volume
Market cap
$155M
52-week high
$7.36
52-week low
$1.47
Average daily volume
1.7M
Financial strength
Current ratio
11.649
Quick ratio
11.138
Long term debt to equity
6.592
Total debt to equity
9.047
Profitability
EBITDA (TTM)
-83.6
Management effectiveness
Return on assets (TTM)
-28.76%
Return on equity (TTM)
-47.96%
Valuation
Price to book
1.2
Price to tangible book (TTM)
1.2
Price to free cash flow (TTM)
-1.948
Free cash flow yield (TTM)
-51.34%
Free cash flow per share (TTM)
-3.234
Growth
Revenue change (TTM)
-100.00%
Earnings per share change (TTM)
-71.58%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Artiva Biotherapeutics, Inc. stock?
Artiva Biotherapeutics, Inc. (ARTV) has a market cap of $155M as of December 17, 2025.
What is the P/E ratio for Artiva Biotherapeutics, Inc. stock?
The price to earnings (P/E) ratio for Artiva Biotherapeutics, Inc. (ARTV) stock is 0 as of December 17, 2025.
Does Artiva Biotherapeutics, Inc. stock pay dividends?
No, Artiva Biotherapeutics, Inc. (ARTV) stock does not pay dividends to its shareholders as of December 17, 2025.
When is the next Artiva Biotherapeutics, Inc. dividend payment date?
Artiva Biotherapeutics, Inc. (ARTV) stock does not pay dividends to its shareholders.
What is the beta indicator for Artiva Biotherapeutics, Inc.?
Artiva Biotherapeutics, Inc. (ARTV) does not currently have a Beta indicator.